Ulinastatin

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Ulinastatin
Accession Number
DB12038
Type
Biotech
Groups
Investigational
Biologic Classification
Protein Based Therapies
Other protein based therapies
Description

Ulinastatin has been investigated for the prevention of Cardiovascular Disease and Adverse Reaction to Drug.

Protein chemical formula
Not Available
Protein average weight
Not Available
Sequences
Not Available
Synonyms
Not Available
Categories
UNII
OR3S9IF86U
CAS number
80449-31-6

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
AbacavirThe serum concentration of Abacavir can be decreased when it is combined with Ulinastatin.
Ambroxol acefyllinateThe serum concentration of Ambroxol acefyllinate can be decreased when it is combined with Ulinastatin.
AmineptineThe serum concentration of Amineptine can be increased when it is combined with Ulinastatin.
AminophyllineThe serum concentration of Aminophylline can be decreased when it is combined with Ulinastatin.
AmitriptylinoxideThe serum concentration of Amitriptylinoxide can be increased when it is combined with Ulinastatin.
AmoxapineThe serum concentration of Amoxapine can be increased when it is combined with Ulinastatin.
BoceprevirThe serum concentration of Ulinastatin can be decreased when it is combined with Boceprevir.
ButriptylineThe serum concentration of Butriptyline can be increased when it is combined with Ulinastatin.
ClarithromycinThe therapeutic efficacy of Clarithromycin can be decreased when used in combination with Ulinastatin.
ClomipramineThe serum concentration of Clomipramine can be increased when it is combined with Ulinastatin.
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347911274
Wikipedia
Ulinastatin

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2Enrolling by InvitationTreatmentAcute Respiratory Distress Syndrome (ARDS)1
2Unknown StatusTreatmentInhalation Injury1
3RecruitingTreatmentOral Mucositis (Ulcerative) Due to Radiation1
4CompletedNot AvailableAbnormal Aortic Valve1
4CompletedPreventionCardiovascular Disease (CVD)1
4CompletedTreatmentCardiopulmonary Bypass / Surgery, Cardiac1
4CompletedTreatmentCoronary Artery Occlusive Disease1
4Enrolling by InvitationTreatmentCongenital Heart Disease (CHD)1
4RecruitingTreatmentSepsis / Severe Sepsis / Shock, Septic1
4SuspendedTreatmentPancreatitis1
Not AvailableCompletedPreventionRenal Mass1
Not AvailableCompletedTreatmentHepatocellular,Carcinoma1
Not AvailableNot Yet RecruitingPreventionAcute Respiratory Distress Syndrome (ARDS) / Critical Illness1
Not AvailableRecruitingNot AvailableAdverse Reaction to Drug1
Not AvailableUnknown StatusPreventionAcute Aortic Dissection1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Description
Not Available
Kingdom
Organic Compounds
Super Class
Organic Acids
Class
Carboxylic Acids and Derivatives
Sub Class
Amino Acids, Peptides, and Analogues
Direct Parent
Peptides
Alternative Parents
Not Available
Substituents
Not Available
Molecular Framework
Not Available
External Descriptors
Not Available

Drug created on October 20, 2016 15:14 / Updated on August 02, 2018 06:33